Literature DB >> 30238390

Visualization of the Breakdown of the Axonal Transport Machinery: a Comparative Ultrastructural and Immunohistochemical Approach.

Sebastian Rühling1, Franziska Kramer1, Selina Schmutz1, Sandra Amor2,3, Zhan Jiangshan1, Christoph Schmitz1, Markus Kipp1, Tanja Hochstrasser4.   

Abstract

Axonal damage is a major factor contributing to disease progression in multiple sclerosis (MS) patients. On the histological level, acute axonal injury is most frequently analyzed by anti-amyloid precursor protein immunohistochemistry. To what extent this method truly detects axonal injury, and whether other proteins and organelles are as well subjected to axonal transport deficits in demyelinated tissues is not known. The aim of this study was to correlate ultrastructural morphology with the immunohistochemical appearance of acute axonal injury in a model of toxin-induced oligodendrocyte degeneration. C57BL/6J mice were intoxicated with 0.25% cuprizone to induce demyelination. The corpus callosum was investigated by serial block-face scanning electron microscopy (i.e., 3D EM), immunohistochemistry, and immunofluorescence microscopy. Brain tissues of progressive MS patients were included to test the relevance of our findings in mice for MS. Volumes of axonal swellings, determined by 3D EM, were comparable to volumes of axonal spheroids, determined by anti-APP immunofluorescence stains. Axonal swellings were present at myelinated and non-myelinated axonal internodes. Densities of amyloid precursor protein (APP)+ spheroids were highest during active demyelination. Besides APP, vesicular glutamate transporter 1 and mitochondrial proteins accumulated at sites of axonal spheroids. Such accumulations were found as well in lesions of progressive MS patients. In this correlative ultrastructural-immunohistochemical study, we provide strong evidence that breakdown of the axonal transport machinery results in focal accumulations of mitochondria and different synaptic proteins. We provide new marker proteins to visualize acute axonal injury, which helps to further understand the complex nature of axonal damage in progressive MS.

Entities:  

Keywords:  APP; Axonal damage; Cuprizone; Mitochondria; VGLUT1

Mesh:

Substances:

Year:  2018        PMID: 30238390     DOI: 10.1007/s12035-018-1353-9

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  49 in total

1.  Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.

Authors:  E H Koo; S S Sisodia; D R Archer; L J Martin; A Weidemann; K Beyreuther; P Fischer; C L Masters; D L Price
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

2.  Axonal damage in acute multiple sclerosis lesions.

Authors:  B Ferguson; M K Matyszak; M M Esiri; V H Perry
Journal:  Brain       Date:  1997-03       Impact factor: 13.501

3.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

4.  Acute axonal damage in three different murine models of multiple sclerosis: A comparative approach.

Authors:  Katharina Marie Höflich; Cordian Beyer; Tim Clarner; Christoph Schmitz; Stella Nyamoya; Markus Kipp; Tanja Hochstrasser
Journal:  Brain Res       Date:  2016-09-01       Impact factor: 3.252

Review 5.  Vesicular glutamate transporters (VGLUTs): the three musketeers of glutamatergic system.

Authors:  Monika Liguz-Lecznar; Jolanta Skangiel-Kramska
Journal:  Acta Neurobiol Exp (Wars)       Date:  2007       Impact factor: 1.579

6.  Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.

Authors:  Maren Lindner; Jantje Fokuhl; Franziska Linsmeier; Corinna Trebst; Martin Stangel
Journal:  Neurosci Lett       Date:  2009-02-10       Impact factor: 3.046

7.  Amyloid precursor protein (APP) regulates synaptic structure and function.

Authors:  Sheue-Houy Tyan; Ann Yu-Jung Shih; Jessica J Walsh; Hiroko Maruyama; Floyd Sarsoza; Lawrence Ku; Simone Eggert; Patrick R Hof; Edward H Koo; Dara L Dickstein
Journal:  Mol Cell Neurosci       Date:  2012-08-03       Impact factor: 4.314

8.  GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue.

Authors:  C Nolte; M Matyash; T Pivneva; C G Schipke; C Ohlemeyer; U K Hanisch; F Kirchhoff; H Kettenmann
Journal:  Glia       Date:  2001-01       Impact factor: 7.452

9.  Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination.

Authors:  J P Buschmann; K Berger; H Awad; T Clarner; C Beyer; M Kipp
Journal:  J Mol Neurosci       Date:  2012-04-22       Impact factor: 3.444

10.  Reduction in parvalbumin-positive interneurons and inhibitory input in the cortex of mice with experimental autoimmune encephalomyelitis.

Authors:  Anna Falco; Roberta Pennucci; Elena Brambilla; Ivan de Curtis
Journal:  Exp Brain Res       Date:  2014-04-26       Impact factor: 1.972

View more
  6 in total

1.  Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5.

Authors:  Newshan Behrangi; Leo Heinig; Linda Frintrop; Emily Santrau; Jens Kurth; Bernd Krause; Dimitrinka Atanasova; Tim Clarner; Athanassios Fragoulis; Markus Joksch; Henrik Rudolf; Sven G Meuth; Sarah Joost; Markus Kipp
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

2.  Nrf2 deficiency increases oligodendrocyte loss, demyelination, neuroinflammation and axonal damage in an MS animal model.

Authors:  Anna Nellessen; Stella Nyamoya; Adib Zendedel; Alexander Slowik; Christoph Wruck; Cordian Beyer; Athanassios Fragoulis; Tim Clarner
Journal:  Metab Brain Dis       Date:  2019-09-16       Impact factor: 3.584

3.  Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination.

Authors:  Tanja Hochstrasser; Sebastian Rühling; Kerstin Hecher; Kai H Fabisch; Uta Chrzanowski; Matthias Brendel; Florian Eckenweber; Christian Sacher; Christoph Schmitz; Markus Kipp
Journal:  Cells       Date:  2019-09-03       Impact factor: 6.600

Review 4.  The Cuprizone Model: Dos and Do Nots.

Authors:  Jiangshan Zhan; Teresa Mann; Sarah Joost; Newshan Behrangi; Marcus Frank; Markus Kipp
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

5.  Aquaporin-4 Expression during Toxic and Autoimmune Demyelination.

Authors:  Sven Olaf Rohr; Theresa Greiner; Sarah Joost; Sandra Amor; Paul van der Valk; Christoph Schmitz; Markus Kipp
Journal:  Cells       Date:  2020-09-28       Impact factor: 6.600

6.  Complement-associated loss of CA2 inhibitory synapses in the demyelinated hippocampus impairs memory.

Authors:  Valeria Ramaglia; Mohit Dubey; M Alfonso Malpede; Naomi Petersen; Sharon I de Vries; Shanzeh M Ahmed; Dennis S W Lee; Geert J Schenk; Stefan M Gold; Inge Huitinga; Jennifer L Gommerman; Jeroen J G Geurts; Maarten H P Kole
Journal:  Acta Neuropathol       Date:  2021-06-25       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.